Magnesium based alloys, especially Mg-Ca alloys, are biocompatible substrates with mechanical properties similar to those of bones. The biodegradable alloys of Mg-Ca provide sufficient mechanical strength in load carrying applications as opposed to biopolymers and also they avoid stress shielding and secondary surgery inherent with permanent metallic implant materials. The main issue facing a biodegradable Mg-Ca alloy is the fast degradation in the aggressive physiological environment of the body. The alloy's corrosion is proportional with the dissolution of the Mg in the body: the reaction with the water generates magnesium hydroxide and hydrogen. The accelerated corrosion will lead to early loss of the alloy's mechanical integrity. The degradation rate of an alloy can be improved mainly through tailoring the composition and by carrying out surface treatments. This research focuses on the ability to adjust degradation rate of Mg-Ca alloys by an original method and studies the biological activity of the resulted specimens. A new Mg-Ca alloy, with a Si gradient concentration from the surface to the interior of the material, was obtained. The surface morphology was investigated using scanning electron microscopy (VegaTescan LMH II, SE detector, 30 kV), X-ray diffraction (X'Pert equipment) and energy dispersive Xray (Bruker EDS equipment). In vivo degradation behavior, biological compatibility and activity of Mg-Ca alloys with/without Si gradient concentration were studied with an implant model (subcutaneous and bony) in rats. The organism response to implants was characterized by using radiological (plain X-rays and computed tomography), biochemical and histological methods of investigation. The results sustained that Si gradient concentration can be used to control the rate of degradation of the Mg-Ca alloys for enhancing their biologic activity in order to facilitate bone tissue repair. (C) 2015 Elsevier B.V. All rights reserved.